The round was led by Broadview Ventures with participation from new and existing angel investors.
The company, which intends to raise a total of $3.5m, intends to use the funds to finance the development and First-In-Man studies of its platform product, the CardioPort™.
Founded in 2015 by Pedro del Nido MD, Chief of Cardiac Surgery at Boston Children’s Hospital, and Professor of Child Surgery at Harvard Medical School, and by Nikolay Vasilyev MD, Staff Scientist at Boston Children’s Hospital, and Assistant Professor of Surgery at Harvard Medical School, and led by Farzad Parsaie, CEO, Nido is advancing the CardioPort, a novel patented platform designed to enable video-endoscopic trans-cardiac surgical repairs inside the beating heart.
Based on technology developed at Boston Children’s Hospital, the device is designed to be inserted through small incisions in the chest and heart wall for intracardiac procedures. It allows video-endoscopic visualization through a camera and light source encased in a bulb lens.
The device body also includes a channel through which standard thoracoscopic/laparoscopic instruments and catheter-based device delivery systems may be inserted into the beating heart, and a fluid purging system to prevent air and debris from entering the bloodstream during instrument insertion.
The initial clinical application is to repair congenital heart defects.
The company has also received a $1.4m Small Business Technology Transfer (STTR) grant from the National Institutes of Health to support this work.